Virtual Reality Mirror Therapy With Focused Object-Directed Attention System

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-80
SponsorNational Cheng-Kung University Hospital

About this trial

In this study, the investigators hypothesized that Virtual Reality Mirror Therapy with Focused Object-Directed Attention (VRMTFOA) would yield superior therapeutic effects compared to conventional Virtual Reality Mirror Therapy (VRMT) in individuals with unilateral stroke.

The aim of this study is to compare the immediate effects of a single session of VRMT, VRMTFOA, and VRMTFOA with auditory feedback on upper extremity function and brain activity in stroke patients.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Clinical diagnosis of stroke with unilateral side involved;

A score of Mini-mental state examination greater than 24 for proving higher mental function;

Time of onset > 6 months before treatment begins;

Premorbid right-handedness.

Disqualifiers

Severe vision impairment;

Major cognitive-perceptual deficit;

Other brain disease.

Trial design

Design model

Parallel

Treatments tested in this trial

  • task-oriented training

    Other intervention

    Virtual Reality Mirror Therapy combined with Motor training targeted to goals that are relevant to the functional needs of the patient

Treatment groups

54 Participants
are divided into 3 treatment groups
Group A: Virtual Reality Mirror Therapy GroupActive comparator 1 intervention
Group B: Virtual Reality Mirror Therapy with Focused Object-Directed Attention (VRMTFOA)Experimental treatment 1 intervention
Group C: VRMTFOA with auditory feedbackActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in the result of Fugl-Meyer assessment (FMA) for motor function of upper extremity test

Each item is rated on a three-point ordinal scale (2 points for the detail being performed completely, 1 point for the detail being performed partially, and 0 for the detail not being performed). The maximum motor performance score is 66 points for the upper extremity.

Time frame
baseline, 9 weeks and 21 weeks

Secondary outcomes

1

Change in the result of Modified Ashworth scale (MAS)

Muscle tone is defined by assess muscle tone by evaluating resistance to passive stretch, reflecting the level of spasticity, with scores ranging from 0 (no increase in tone) to 4 (rigidity in flexion or extension).

Time frame
baseline, 9 weeks and 21 weeks
2

Change in the result of Box and blocks test

The score is the number of blocks carried from one box to the other in one minute. Higher values represent a better outcome.

Time frame
baseline, 9 weeks and 21 weeks
3

Change in the result of Semmes-Weinstein monofilament (SWM) test

The Semmes-Weinstein monofilamenttest examines the cutaneous pressure threshold, range from 1.65-6.65. Higher values represent a worse outcome.

Time frame
baseline, 9 weeks and 21 weeks
4

Change in the result of Motor Activity Log

Semi-structured interview examine how much and how well the subject uses their more-affected arm for 30 ADLs. Score range from 0-5. Higher values represent a better outcome.

Time frame
baseline, 9 weeks and 21 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.